By analyzing the pathological alterations in the early developmental stages of the Pomgnt2-KO mouse brain, we provide deeper insights into how loss of dystroglycan function gives rise to the brain malformations in dystroglycanopathy. Here, DAG1 is linked to neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.